Emergent BioSolutions Inc. - 8-K Filing

Emergent BioSolutions CEO to present at H.C. Wainwright conference with investor presentation filed as Exhibit 99.1 (Items: 7.01 Regulation FD Disclosure, 9.01 Financial Statements and Exhibits)

SEC EDGAR ·

Tickers: $EBS

Read the full article at SEC EDGAR

More Regulatory news